Autoimmune Hemolytic Anemia Following Kidney Transplant: The Role of Tacrolimus and Transition to Everolimus in a Pediatric Case

Tacrolimus-associated AIHA is an uncommon complication among kidney transplant recipients, necessitating heightened awareness and timely intervention. Transitioning to alternative immunosuppressive therapies, such as everolimus or sirolimus, may prove effective in managing this condition. Although previous reports have described transitions from tacrolimus to sirolimus, this case marks the first documented instance of a switch to everolimus.